This opportunity has closed
The submission deadline was May 15, 2026. This page is kept for reference purposes.
Pharmaceutical Products for CDER Research Studies - IDIQ
Actions
Create a free account to analyze this opportunity, get daily notifications, and win more bids with Narwin.ai
Additional Information
Source
Sam.gov
Type
RFP
Status
closed
Contract Type
Combined Synopsis/Solicitation
Reference Number
75F40126Q132721
Contact Name
Nick Sartain
Contact Email
Contact Phone
3017961988
Organization Province / State
MD
Organization Country
USA
Last Updated
May 16, 2026
Frequently Asked Questions
When is the proposal submission deadline?
The proposal submission deadline is May 15, 2026 (Overdue).
Note: This opportunity has already closed. See similar active opportunities above.
What NAICS codes apply to this opportunity?
The applicable NAICS codes are:
Where can I submit a proposal or get solicitation documents?
You can access the full solicitation documents and submit your proposal at the official source:
Visit Official SourceAdditional Details
NAICS Codes
Similar open opportunities 5 available
Since this opportunity has closed, here are similar active opportunities you may be interested in:
FDA/CDRH Scientific Technical Capacity for Regulatory Review
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
6505--FY27 Lenalidomide BPA
6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC
Explore More Opportunities
Open tenders from this agency
- FDA/CDRH Scientific Technical Capacity for Regulatory Review
RFP · Due November 17, 2026
- Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
RFP · Due November 5, 2026
Historical Contracts
Research past opportunities
All Active Opportunities
Search all current contracts
Narwin.ai is a great way to find government contracts and opportunities. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.